ArticleTranslational oncology2019

UAB30, A Novel Rexinoid Agonist, Decreases Stemness In Group 3 Medulloblastoma Human Cell Line Xenografts.

Adele P Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.